Platinum Priority – Prostate CancerEditorial by Howard I. Scher on pp. 1039–1041 of this issueSurvival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
Editorial by Howard I. Scher on pp. 1039–1041 of this issue
Under a Creative Commons license
open access
Keywords
Prostate cancer
Natural history
Survival
Time to progression
Control arm cohort
Hormone-naïve
Metastatic
Prognostic factors
Prospective data
Cited by (0)
Copyright © 2014 The Authors. Published by Elsevier B.V.